TOCQUEVILLE ASSET MANAGEMENT L.P. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 2 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$2,000
-60.0%
10,0000.0%0.00%
Q3 2018$5,0000.0%10,0000.0%0.00%
Q2 2018$5,000
-78.3%
10,0000.0%0.00%
Q1 2018$23,000
-17.9%
10,0000.0%0.00%
Q4 2017$28,000
-3.4%
10,0000.0%0.00%
Q3 2017$29,000
+16.0%
10,0000.0%0.00%
Q2 2017$25,000
-30.6%
10,0000.0%0.00%
Q1 2017$36,000
+2.9%
10,0000.0%0.00%
Q4 2016$35,000
-12.5%
10,0000.0%0.00%
Q3 2016$40,000
-54.5%
10,000
-50.0%
0.00%
-100.0%
Q2 2016$88,000
+131.6%
20,000
+100.0%
0.00%0.0%
Q1 2016$38,000
-96.7%
10,000
-86.4%
0.00%
-93.8%
Q4 2015$1,151,000
+130.2%
73,400
+54.9%
0.02%
+128.6%
Q3 2015$500,000
-59.1%
47,400
-2.3%
0.01%
-50.0%
Q2 2015$1,223,000
-7.6%
48,500
+2.1%
0.01%
-12.5%
Q1 2015$1,324,000
+93.6%
47,500
+26.7%
0.02%
+128.6%
Q4 2014$684,000
+83.4%
37,500
+30.2%
0.01%
+75.0%
Q3 2014$373,000
-32.1%
28,800
-14.4%
0.00%
-20.0%
Q2 2014$549,000
-37.7%
33,650
-32.5%
0.01%
-58.3%
Q1 2014$881,000
-22.3%
49,850
+6.4%
0.01%
-20.0%
Q4 2013$1,134,000
+26.0%
46,850
+84.4%
0.02%
+36.4%
Q3 2013$900,000
+179.5%
25,400
+23.3%
0.01%
+175.0%
Q2 2013$322,00020,6000.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2019
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 1,025,000$24,815,00031.36%
TSP Capital Management Group, LLC 836,342$20,248,0008.80%
Iguana Healthcare Management, LLC 200,000$4,842,0002.76%
First Light Asset Management, LLC 116,096$2,811,0002.38%
SECTORAL ASSET MANAGEMENT INC 2,227,688$53,932,0002.33%
BENNETT LAWRENCE MANAGEMENT L L C/NY 550,735$13,334,0002.05%
Eventide Asset Management 257,000$6,222,0001.92%
Redmile Group, LLC 397,951$9,634,0001.19%
ARDSLEY ADVISORY PARTNERS LP 357,000$8,643,0001.15%
Rhenman & Partners Asset Management AB 90,000$2,179,0000.85%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders